Point-of-Care Ultrasound (PoCUS) Low-Contact Curriculum Using Near-Peer Training and Remote Supervision
Launched by NATIONAL TAIWAN UNIVERSITY CLINICAL TRIAL CENTER · Jan 10, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to teach medical students how to use a portable ultrasound machine, known as point-of-care ultrasound (PoCUS). This method allows doctors to quickly assess patients' health right at their bedside, which can improve patient care. The study aims to create a training program that minimizes physical contact, using small group teaching and remote supervision, especially important during the COVID-19 pandemic. Researchers will compare this new teaching approach with traditional methods to see which is more effective for learning this valuable skill.
To participate in this trial, you must be a fifth- or sixth-year medical student at National Taiwan University College of Medicine and at least 20 years old. If you decide to join, you can expect to engage in hands-on training, either through the new curriculum or a standard approach, and your progress will be assessed through practical exams. This study is crucial not only for improving ultrasound training but also for ensuring that medical education continues effectively during challenging times.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ■Fifth- or sixth-year medical students at National Taiwan University College of Medicine, aged 20 or older.
- Exclusion Criteria:
- • Unwillingness to participate in the study.
- • Prior exposure to the bedside ultrasound course at National Taiwan University College of Medicine.
About National Taiwan University Clinical Trial Center
The National Taiwan University Clinical Trial Center is a leading institution dedicated to advancing medical research through the design, implementation, and management of clinical trials. Affiliated with National Taiwan University, the center leverages its academic expertise and state-of-the-art facilities to facilitate innovative studies across various therapeutic areas. Committed to upholding the highest ethical standards and regulatory compliance, the center collaborates with healthcare professionals, researchers, and industry partners to enhance patient care and contribute to the global medical community. Through its rigorous approach, the center aims to accelerate the development of new treatments and improve health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported